Related Experiment Video
Updated: May 24, 2026
05:19
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
Epigenetics of bladder cancer
1Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea. wjkim@chungbuk.ac.kr
Methods in Molecular Biology (Clifton, N.J.)
|February 24, 2012
Summary
Epigenetic changes are linked to bladder cancer development and outcomes. Detecting these epigenetic markers in samples may offer a more sensitive approach for diagnosis and treatment than current methods.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epigenetic alterations are increasingly recognized as critical drivers in bladder cancer progression.
- Current diagnostic and prognostic methods for bladder cancer have limitations.
- The potential for reversibility of epigenetic changes offers therapeutic opportunities.
Purpose of the Study:
- To explore the role of epigenetic changes in bladder cancer.
- To evaluate the feasibility and sensitivity of detecting epigenetic markers in biological specimens.
- To assess the potential utility of epigenetic markers in bladder cancer detection, prognosis, and treatment.
Main Methods:
- Analysis of epigenetic modifications in bladder cancer tissues and body fluids.
- Comparison of epigenetic marker detection with conventional diagnostic techniques.
Main Results:
- Epigenetic changes are strongly associated with bladder cancer development and patient prognosis.
- Detection of epigenetic markers in specimens shows potential for high sensitivity.
- Epigenetic markers may outperform conventional molecular markers for clinical applications.
Conclusions:
- Epigenetic markers represent a promising avenue for improving bladder cancer management.
- Reversibility of epigenetic changes could lead to novel therapeutic strategies.
- Further research into epigenetic markers is warranted for clinical translation in bladder cancer.
